CLINICAL RESEARCH

临床研究计划致力于针对癌症诊断，预后，治疗和生存的各个方面的高质量临床研究。该计划列出了29名成员，他们在癌症护理和研究的各个方面都具有不同的专业知识。在过去的3年里，项目的进展和发展突出表现在招聘了对新研究感兴趣的教师，有针对性地在选定的领域开展转化研究活动，以及内部和合作小组临床试验和推广项目的增长和加强。该计划的一个主要重点是乳腺癌，最近妇科和泌尿生殖系统癌症的研究活动有所增加。该计划中的具体研究范围从与癌症诊断相关的成熟行为研究，到包括内部和合作组治疗试验在内的临床干预措施，到国家手术试验的开发，到包括创新发展治疗研究在内的首次人体研究，到与医生，护理和患者教育相关的教育研究和计划。项目负责人是Hyman Muss，医学博士，医学教授和临床研究副主任。

The Clinical Research Program is dedicated to high quality clinical research directed at all aspects of cancer diagnosis, prognosis, treatment, and survivorship. The program lists 29 members with diverse expertise in all aspects of cancer care and research. Program progress and development sin the last 3 years are highlighted by recruitment of faculty with new research interested, targeted efforts to develop translational research activities in selected areas, and growth and enhancement of in- house and cooperative group clinical trials and outreach program./ A major focus of this program is on breast cancer, with recent growth of research activities in gynecologic and genitourinary cancer. Specific research studies in the program range from well-established behavioral research related to cancer diagnosis, to clinical interventions including in- house and cooperative group therapeutic trials, to development of a national surgical trial, to first-in-human studies including innovative developmental therapeutic research, to educational studies and programs related to physician, nursing and patient education. The Program Leader is Hyman Muss, M.D., Professor of Medicine and Associate Director for Clinical Research.